← back to search

Mark W. Douglas

The University of Sydney · AU
Area of research
Epidemiology · Hepatology
Research interest
Research interests include Hepatitis C virus research, Hepatitis B Virus Studies, Liver Disease Diagnosis and Treatment, and Immune Cell Function and Interaction.
h-index
35
citations
3,934
works
136
NIH funding
primary concept
email

Recent publications

The Impact of Hepatitis B Surface Antigen Reduction via Small Interfering RNA Treatment on Natural and Vaccine (BRII-179)-Induced Hepatitis B Virus-Specific Humoral and Cellular Immune Responses
Gastroenterology 2025cited by 24position: middledoi
Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level
EBioMedicine 2023cited by 55position: middledoi
Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals
JHEP Reports 2022cited by 40position: middledoi
Epidemiology of Coronavirus Disease in Gansu Province, China, 2020
Emerging infectious diseases 2020cited by 123position: middledoi
The Lived Experience of Chronic Hepatitis B: A Broader View of Its Impacts and Why We Need a Cure
Viruses 2020cited by 113position: lastdoi
HBV vaccination and HBV infection induces HBV-specific natural killer cell memory
Gut 2020cited by 55position: middledoi
COVID-19: The Immune Responses and Clinical Therapy Candidates
International Journal of Molecular Sciences 2020cited by 36position: lastdoi
Macrophage Coordination of the Interferon Lambda Immune Response
Frontiers in Immunology 2019cited by 75position: middledoi
KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B
Journal of Hepatology 2019cited by 63position: middledoi
The paradox of HBV evolution as revealed from a 16th century mummy
PLoS Pathogens 2018cited by 98position: middledoi
IFN-λ3, not IFN-λ4, likely mediates IFNL3–IFNL4 haplotype–dependent hepatic inflammation and fibrosis
Nature Genetics 2017cited by 97position: middledoi
Zinc is a potent and specific inhibitor of IFN-λ3 signalling
Nature Communications 2017cited by 56position: middledoi
The antiviral role of zinc and metallothioneins in hepatitis C infection
Journal of Viral Hepatitis 2017cited by 52position: middledoi
MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C
Nature Communications 2016cited by 128position: middledoi
Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes
Hepatology 2016cited by 124position: middledoi
Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease
Nature Communications 2015cited by 174position: middledoi
FibroGENE: A gene-based model for staging liver fibrosis
Journal of Hepatology 2015cited by 77position: middledoi
IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection
Journal of Hepatology 2014cited by 41position: middledoi
Virus induced inflammation and cancer development
Cancer Letters 2013cited by 88position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Scott Read · The University of Sydney6 papers (2013–2020)Golo Ahlenstiel · The University of Sydney6 papers (2014–2020)Jacob George · The University of Sydney4 papers (2019–2020)Ratna Sari Wijaya · University of Southampton3 papers (2019–2020)Jacob George · The University of Sydney3 papers (2014–2017)David Booth · The University of Sydney3 papers (2014–2019)David van der Poorten · Westmead Hospital2 papers (2019–2020)Stephen D. Schibeci · The University of Sydney2 papers (2019–2020)Mohammed Eslam · The University of Sydney2 papers (2014–2019)Mahmoud Karimi Azardaryany · The University of Sydney2 papers (2019–2020)Rita Lin · National Taiwan University Hospital2 papers (2019–2020)Lawrence Yuen · Westmead Hospital2 papers (2019–2019)Grant P. Parnell · University of Sydney2 papers (2017–2020)Vincent Lam · University of Southern California2 papers (2019–2019)David R. Booth · Naval Medical Center San Diego2 papers (2017–2020)Kristina M. Cook · The University of Sydney1 papers (2017–2017) · 1 papers (2025–2025)Ariel Lee · Dartmouth College1 papers (2025–2025)Mehdi Ramezani–Moghadam · The University of Sydney1 papers (2019–2019)Naomi R. Truong · The University of Sydney1 papers (2020–2020)